Developing a national strategy for combating counterfeit medicines
Background Counterfeit medicines pose a worldwide problem to governments, pharmaceutical companies and patients, meaning a systemic and comprehensive approach needs to be adopted by medicines regulatory agencies. The UK’s Medicines and Health Regulatory Agency (MHRA) was one of the first national ag...
| Main Author: | |
|---|---|
| Published: |
University of East Anglia
2015
|
| Subjects: | |
| Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.687876 |